Entecavir hydrate
Synonym(s):2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
- CAS NO.:209216-23-9
- Empirical Formula: C12H17N5O4
- Molecular Weight: 295.3
- MDL number: MFCD09754448
- EINECS: 606-668-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-10-28 23:16:16
What is Entecavir hydrate?
The Uses of Entecavir hydrate
Entecavir hydrate is an oral antiviral drug used in the treatment of hepatitis B infection. Entecavir hydrate is a nucleoside analog (more specifically, a guanine analogue) that inhibits reverse transcription, DNA replication and transcription in the vira
The Uses of Entecavir hydrate
Entecavir Monohydrate could be a useful compound for treating hepatitis virus B infection.
Definition
ChEBI: The monohydrate form of entecavir. A synthetic analogue of 2'-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus. It is phosphorylated intracellularly to the active triphosp ate form, which competes with deoxyguanosine triphosphate, the natural substrate of hepatitis B virus reverse transcriptase, inhibiting every stage of the enzyme's activity, although it has no activity against HIV. Enteclavir is used for the treatment of c ronic hepatitis B.
brand name
Baraclude (Bristol-Myers Squibb).
Description
Entecavir hydrate is the monohydrate form of entecavir. A synthetic analogue of 2'-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus.
Properties of Entecavir hydrate
Melting point: | >220° |
alpha | D +35.0° (c = 0.38 in water) |
Density | 1.81 |
storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
solubility | DMSO (Slightly), Methanol (Sparingly), Water (Slightly, Heated, Sonicated) |
form | Solid |
color | White to Off-White |
Merck | 14,3595 |
CAS DataBase Reference | 209216-23-9(CAS DataBase Reference) |
Safety information for Entecavir hydrate
Signal word | Danger |
Pictogram(s) |
Health Hazard GHS08 |
GHS Hazard Statements |
H351:Carcinogenicity H372:Specific target organ toxicity, repeated exposure |
Precautionary Statement Codes |
P201:Obtain special instructions before use. P202:Do not handle until all safety precautions have been read and understood. P260:Do not breathe dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P308+P313:IF exposed or concerned: Get medical advice/attention. |
Computed Descriptors for Entecavir hydrate
Abamectin manufacturer
BDR Pharmaceuticals International Pvt Ltd
New Products
Bromine 99.5% AR (4 x 500ml) Fehling's Solution No. B Amino Acid Kit of 23 items set Ammonium Molybdate Reagent Solution Beam's Reagent Solution Ehrlich's Reagent For detection of urobillinogen 4-((2-isopropoxyethoxy)methyl)phenol 4-Hydroxy Carbazole Amino Salicylic Acid. U.S.P. 2 – Methoxy – 5- Sulfamoyl Benzoic acid 1,2,3,4-Tetrahydrocarbazol-4-one Acetone Isobutryl oxime ester Curcuma aromatica Oil Curry leaf Extract Terminalia bellirica Extract Aloe vera extract 200x Withania somnifera (Ashwagandha Extract) Citrus bioflavonoids Extract Ethyl 3-(Pyridin-2-Ylamino)Propanoate Bilastine -IP/BP/ Cypermethric Acid Chloride Methyl Di Chloride (Mdc) 5-Nitrosalicylaldehyde 5-(Difluoromethoxy)-2-Mercapto-1H-Benzimidazole- IP/BP/Related products of tetrahydrofuran
You may like
-
209216-23-9 Entecavir Monohydrate USP/IP/PH.Eur 98%View Details
209216-23-9 -
209216-23-9 98%View Details
209216-23-9 -
Entecavir Monohydrate CAS 209216-23-9View Details
209216-23-9 -
Entecavir monohydrate 209216-23-9 98%View Details
209216-23-9 -
Entecavir monohydrate 98%View Details
209216-23-9 -
209216-23-9 Entecavir monohydrate 98%View Details
209216-23-9 -
Entecavir monohydrate 98% (HPLC) CAS 209216-23-9View Details
209216-23-9 -
Entecavir monohydrate CAS 209216-23-9View Details
209216-23-9